Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply to C.G. Rusthoven et al.
Tran PT, Bivalacqua TJ, Dicker AP. Tran PT, et al. Among authors: bivalacqua tj. J Clin Oncol. 2015 Jun 10;33(17):1990-1. doi: 10.1200/JCO.2015.60.9560. Epub 2015 Apr 6. J Clin Oncol. 2015. PMID: 25847932 No abstract available.
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.
Kates M, Chappidi MR, Brant A, Milbar N, Sopko NA, Meyer C, Terezakis SA, Herman JM, Efron JE, Safar B, Tran PT, Ahuja N, Pierorazio PM, Bivalacqua TJ. Kates M, et al. Among authors: bivalacqua tj. Bladder Cancer. 2017 Jul 27;3(3):191-199. doi: 10.3233/BLC-170104. Bladder Cancer. 2017. PMID: 28824947 Free PMC article.
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
Lombardo KA, Obradovic A, Singh AK, Liu JL, Joice G, Kates M, Bishai W, McConkey D, Chaux A, Eich ML, Rezaei MK, Netto GJ, Drake CG, Tran P, Matoso A, Bivalacqua TJ. Lombardo KA, et al. Among authors: bivalacqua tj. J Pathol. 2022 Feb;256(2):223-234. doi: 10.1002/path.5830. Epub 2021 Dec 10. J Pathol. 2022. PMID: 34731491 Free PMC article.
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.
Reyes DK, Trock BJ, Tran PT, Pavlovich CP, Deville C, Allaf ME, Greco SC, Song DY, Bivalacqua TJ, Han M, Partin AW, Sartor AO, Rowe SP, Pienta KJ. Reyes DK, et al. Among authors: bivalacqua tj. Med Oncol. 2022 Apr 28;39(5):63. doi: 10.1007/s12032-022-01662-7. Med Oncol. 2022. PMID: 35478055 Clinical Trial.
483 results